Glycans in Diseases and Therapeutics

Glycomedicine functions a pivotal role in cell-cell adhesion i.e. a tool utilized by cells of the immune system through sugar-binding proteins called lectins, which identify specific carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play foremost roles in numerous biological phenomena as well as in various pathophysiological processes. Many researchers have now understood that glycosylation, i.e. the addition of glycans to a protein backbone, is the most abundant post translational modification reactions and is a significant field of research and sometimes they require a glycobiology method to be exploited.

  • Genetic disorder of glycosylations
  • Glycoprotein ligand
  • Growth factors and oncogenes
  • Genetically engineered glycan

Related Conference of Glycans in Diseases and Therapeutics

January 19-20, 2026

17th International Conference on Biofuels and Bioenergy

Barcelona, Spain
May 04-05, 2026

7th International Conference on Drug Chemistry

Paris, France
September 03-04, 2026

16th World Glycobiology Congress

Aix-en-Provence, France
September 21-22, 2026

24th International Conference on Structural Biology

A Coruna, Spain

Glycans in Diseases and Therapeutics Conference Speakers